Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Dec;51(12):806-13.
doi: 10.1136/jmedgenet-2014-102798. Epub 2014 Oct 23.

Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability

David Hunt  1 , Richard J Leventer  2 , Cas Simons  3 , Ryan Taft  4 , Kathryn J Swoboda  5 , Mary Gawne-Cain  6 ; DDD study; Alex C Magee  7 , Peter D Turnpenny  8 , Diana Baralle  9
Affiliations
Free PMC article
Case Reports

Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability

David Hunt et al. J Med Genet. 2014 Dec.
Free PMC article

Abstract

Background: De novo mutations are emerging as an important cause of neurocognitive impairment, and whole exome sequencing of case-parent trios is a powerful way of detecting them. Here, we report the findings in four such trios.

Methods: The Deciphering Developmental Disorders study is using whole exome sequencing in family trios to investigate children with severe, sporadic, undiagnosed developmental delay. Three of our patients were ascertained from the first 1133 children to have been investigated through this large-scale study. Case 4 was a phenotypically isolated case recruited into an undiagnosed rare disorders sequencing study.

Results: Protein-altering de novo mutations in PURA were identified in four subjects. They include two different frameshifts, one inframe deletion and one missense mutation. PURA encodes Pur-α, a highly conserved multifunctional protein that has an important role in normal postnatal brain development in animal models. The associated human phenotype of de novo heterozygous mutations in this gene is variable, but moderate to severe neurodevelopmental delay and learning disability are common to all. Neonatal hypotonia, early feeding difficulties and seizures, or 'seizure-like' movements, were also common. Additionally, it is suspected that anterior pituitary dysregulation may be within the spectrum of this disorder. Psychomotor developmental outcomes appear variable between patients, and we propose a possible genotype-phenotype correlation, with disruption of Pur repeat III resulting in a more severe phenotype.

Conclusions: These findings provide definitive evidence for the role of PURA in causing a variable syndrome of neurodevelopmental delay, learning disability, neonatal hypotonia, feeding difficulties, abnormal movements and epilepsy in humans, and help clarify the role of PURA in the previously described 5q31.3 microdeletion phenotype.

Keywords: Clinical genetics; Developmental; Epilepsy and seizures; Neurology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Depictions of the four mutations identified within PURA. (A) Schematic of Purα, depicting sites of the different mutations identified in our patients with respect to the Pur repeat regions (I–III). (B) Sequence alignment illustrating the high level of conservation of amino acids affected by the p.Ile206Phe and p.Phe233del mutations. Asterisk denotes complete conservation, colon denotes high conservation and single dot denotes moderate conservation. (C) and (D) illustrate the respective locations of the p.Ile206Phe and p.Phe233del mutations within the tertiary structure of the protein.
Figure 2
Figure 2
Clinical photographs. Patient 1 is shown at age 1 year 7 months (A and B) and 4 years 7 months (C). Patient 2 is shown at 7 years 3 months (D and E) and 14 years 3 months (F). Patient 3 is shown at 9 years 7 months (G and H) and 12 years 10 months (I). Patient 4 is shown at 6 years 9 months (J and K). While there is no obvious gestalt, all four patients were noted to have quite prominent foreheads with high anterior hairlines. Patients 1, 2 and 4 have mildly hypotonic facies.
Figure 3
Figure 3
Serial MRI brain scans from Patient 4. (A) At 1 week, there is patchy high attenuation within white matter and a right frontal horn cyst, which is not evident on subsequent scans. (B) At 14 months, the white matter appears normal but thickening of tissue at the ependymal margin of the right frontal horn is apparent. (C) At 2 years 2 months, subtle hypomyelination is apparent in that there is poor definition of the grey-white matter boundary in the frontal lobes. (D) At 3 years 10 months, subtle hypomyelination persists. (E) At 5 years, myelination is complete. However, there are excessive extra-axial fluid spaces and there is possible cerebral atrophy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet 2011;45:81–104. - PubMed
    1. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, Beck AE, Tabor HK, Cooper GM, Mefford HC, Lee C, Turner EH, Smith JD, Rieder MJ, Yoshiura K-I, Matsumoto N, Ohta T, Niikawa N, Nickerson DA, Bamshad MJ, Shendure J. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010;42:790–3. - PMC - PubMed
    1. Hoischen A, van Bon BWM, Gilissen C, Arts P, van Lier B, Steehouwer M, de Vries P, de Reuver R, Wieskamp N, Mortier G, Devriendt K, Amorim MZ, Revencu N, Kidd A, Barbosa M, Turner A, Smith J, Oley C, Henderson A, Hayes IM, Thompson EM, Brunner HG, de Vries BBA, Veltman JA. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 2010;42:483–5. - PubMed
    1. Vissers LELM, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, van Bon BWM, Hoischen A, de Vries BBA, Brunner HG, Veltman JA. A de novo paradigm for mental retardation. Nat Genet 2010;42:1109–12. - PubMed
    1. Ku CS, Polychronakos C, Tan EK, Naidoo N, Pawitan Y, Roukos DH, Mort M, Cooper DN. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry 2013;18:141–53. - PubMed

Publication types

MeSH terms

Associated data